Sensitive Cyp3a Substrates With Narrow Therapeutic Index + Mitapivat Interaction

Contraindicatedinteraction on record

Description

PYRUKYND induces CYP3A, decreasing concentrations of sensitive substrates with narrow therapeutic index. Avoid concomitant use.

Mechanism

CYP3A induction

Source: NLP:mitapivat

Related drug profiles

All Sensitive Cyp3a Substrates With Narrow Therapeutic Index interactions →All Mitapivat interactions →
Share this page:XFacebookWhatsAppReddit